Press Releases
Calidi is at the forefront of the genetic medicine revolution in cancer and other indications
Read the Latest
Calidi Biotherapeutics Announces Global Oncolytic Virus-based Immunotherapy License to VetStem Biopharma for its Pioneering Treatment of Cancer in the Veterinary Field
SAN DIEGO, CA / ACCESSWIRE / July 10, 2019 / Calidi Biotherapeutics, Inc., a clinical‐stage…
Calidi Biotherapeutics Announces The Appointment of Medical Oncologist and Expert in Oncolytic Immunotherapies, Dr. Dmitriy Zamarin to Their Scientific Advisory Board
SAN DIEGO (PRWEB) JUNE 03, 2019 – Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at…
Calidi Biotherapeutics Announces The Appointment Of Seasoned Biotech Executive Dr. Ashok Srivastava To Their Scientific Advisory Board
SAN DIEGO, May 30, 2019 /PRNewswire/ — Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at…
Calidi Biotherapeutics Announces A Collaborative Study With The National Institutes Of Health (NIH) On The Therapeutic Potential Of Oncolytic Viruses Delivered By Mesenchymal Stem Cells
SAN DIEGO, May 28, 2019 /PRNewswire/ — Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at…
Calidi Biotherapeutics Releases Recent Interviews of CEO Allan Camaisa
SAN DIEGO (PRWEB) APRIL 15, 2019 Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the…
Calidi Biotherapeutics Launches Scientific and Medical Advisory Board
SAN DIEGO, Jan. 3, 2019 /PRNewswire-PRWeb/ — Calidi Biotherapeutics, Inc., a clinical‐stage biotechnology company at…